XML 90 R78.htm IDEA: XBRL DOCUMENT v3.4.0.3
Supplemental Financial Information (Schedule of Condensed Consolidating Statements of Cash Flows) (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Schedule Of Supplemental Financial Information [Line Items]    
Net cash provided by (used in) operating activities $ 15,354 $ (14,752)
Cash paid for acquisitions (2,314) 0
Purchases of property, plant, and equipment (1,501) (2,022)
Other, net 1,118 (61)
Net proceeds from sale of property and equipment 57 26,181
Net cash (used in) provided by investing activities (2,640) 24,098
Purchase of treasury stock at market prices (414) (356)
Net proceeds from issuance of common stock 133 9
Payments of Debt Issuance Costs (54)  
Intercompany financing 0 0
Excess tax benefit from stock compensation 187 18
Net cash used in financing activities (148) (329)
Effect of exchange rate changes on cash 1,203 (1,327)
Net increase in cash and cash equivalents 13,769 7,690
Cash and cash equivalents at beginning of year 68,858  
Cash and cash equivalents at end of period 82,627  
Gibraltar Industries, Inc.    
Schedule Of Supplemental Financial Information [Line Items]    
Net cash provided by (used in) operating activities (6,557) (6,609)
Cash paid for acquisitions 0  
Purchases of property, plant, and equipment 0 0
Other, net 0 0
Net proceeds from sale of property and equipment 0 0
Net cash (used in) provided by investing activities 0 0
Purchase of treasury stock at market prices (414) (356)
Net proceeds from issuance of common stock 133 9
Payments of Debt Issuance Costs 0  
Intercompany financing 6,651 6,938
Excess tax benefit from stock compensation 187 18
Net cash used in financing activities 6,557 6,609
Effect of exchange rate changes on cash 0 0
Net increase in cash and cash equivalents 0 0
Cash and cash equivalents at beginning of year 0  
Cash and cash equivalents at end of period 0  
Guarantor Subsidiaries    
Schedule Of Supplemental Financial Information [Line Items]    
Net cash provided by (used in) operating activities 23,250 (8,853)
Purchases of property, plant, and equipment (1,356) (1,720)
Other, net 1,118 (61)
Net proceeds from sale of property and equipment 57 26,181
Net cash (used in) provided by investing activities (2,495) 24,400
Purchase of treasury stock at market prices 0 0
Net proceeds from issuance of common stock 0 0
Payments of Debt Issuance Costs (54)  
Intercompany financing (7,143) (6,184)
Excess tax benefit from stock compensation 0 0
Net cash used in financing activities (7,197) (6,184)
Effect of exchange rate changes on cash 0 0
Net increase in cash and cash equivalents 13,558 9,363
Cash and cash equivalents at beginning of year 39,597  
Cash and cash equivalents at end of period 53,155  
Non-Guarantor Subsidiaries    
Schedule Of Supplemental Financial Information [Line Items]    
Net cash provided by (used in) operating activities (1,339) 710
Cash paid for acquisitions 0  
Purchases of property, plant, and equipment (145) (302)
Other, net 0 0
Net proceeds from sale of property and equipment 0 0
Net cash (used in) provided by investing activities (145) (302)
Purchase of treasury stock at market prices 0 0
Net proceeds from issuance of common stock 0 0
Payments of Debt Issuance Costs 0  
Intercompany financing 492 (754)
Excess tax benefit from stock compensation 0 0
Net cash used in financing activities 492 (754)
Effect of exchange rate changes on cash 1,203 (1,327)
Net increase in cash and cash equivalents 211 (1,673)
Cash and cash equivalents at beginning of year 29,261  
Cash and cash equivalents at end of period 29,472  
Eliminations    
Schedule Of Supplemental Financial Information [Line Items]    
Net cash provided by (used in) operating activities 0 0
Cash paid for acquisitions 0  
Purchases of property, plant, and equipment 0 0
Other, net 0 0
Net proceeds from sale of property and equipment 0 0
Net cash (used in) provided by investing activities 0 0
Purchase of treasury stock at market prices 0 0
Net proceeds from issuance of common stock 0 0
Payments of Debt Issuance Costs 0  
Intercompany financing 0 0
Excess tax benefit from stock compensation 0 0
Net cash used in financing activities 0 0
Effect of exchange rate changes on cash 0 0
Net increase in cash and cash equivalents 0 $ 0
Cash and cash equivalents at beginning of year 0  
Cash and cash equivalents at end of period $ 0